Healthcare Investor December 2, 2024
Geoff Cockrell

As the pharma services sector grows, regulators at the Department of Justice and Food and Drug Administration are putting everything from clinical trials to site management under the microscope.

McGuireWoods partner Clint Narver speaks from experience: He joined the firm after serving in leadership roles at both agencies. With host Geoff Cockrell, Clint helps industry stakeholders understand regulators’ enforcement priorities. He covers the responsibilities of clinical...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Govt Agencies, Pharma, Pharma / Biotech, Regulations, Trends
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
US health dept providing Moderna $590 mn to speed mRNA bird flu vaccine
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Insurer-PBM Firms Dominate Medicare Part D Market, Steering Patients to Their Pharmacies
Q&A: The Importance of ASHP’s 2025 Pharmacy Forecast

Share This Article